Stephan F Taylor
Manage Your Profile
About
Stephan F. Taylor received his B.A. from Northwestern University, where he majored in psychology and philosophy, and he went on to receive his M.D. degree in 1988 from Washington University. He completed a residency in psychiatry and a fellowship at the Mental Health Research Institute at the University of Michigan. He was appointed as a lecturer in Psychiatry in 1993, rising through the ranks to Professor in Psychiatry and a Faculty Associate in the Department of Psychology. In 2022, he was installed as the inaugural Albert J. Silverman, M.D., C.M., Research Professor of Psychiatric Disorders. He has carried out multiple administrative roles in the Department of Psychiatry and the medical school. He served on the medical school IRB for 14 years, 8 of those as a vice-chair. In 2015, he was appointed as Co-Associate Chair for Research and Research Regulatory Affairs in Psychiatry, and in October of 2024, he stepped down from that position to take on the role of Interim Chair of the Department of Psychiatry in 2024. In September of 2025, when he was appointed by the dean as the permanent chair of the department. With the chair appointment, he also became the Daniel E. Offutt III Professor of Psychiatry
Links
Taylor.lab.medicine.umich.edu
Center Memberships
-
Center MemberOpioid Research Institute
-
Center Membere-Health and Artificial Intelligence Initiative
-
Center MemberEisenberg Family Depression Center
Research Overview
Dr. Taylor conducts transdiagnostic research in major psychiatric disorders (schizophrenia, obsessive-compulsive disorder, depression, bipolar disorder), using brain mapping (magnetic resonance imaging, magnetic resonance spectroscopy, electroencephalography, positron emission tomography) and brain stimulation technologies (deep brain stimulation [DBS], transcranial magnetic stimulation [TMS]) to understand and treat the pathophysiology of these conditions. His work has also investigated processes and neurocircuits relevant to these diseases, such as the brain systems which underlie emotion, performance monitoring, and cognitive-emotional interactions. He and his colleagues conducted some of the earliest brain imaging work on the neurocircuitry of emotion, synthesizing findings with influential meta-analytic work. He has conducted and led clinical trials of DBS in depression and OCD, as well as leading studies of non-invasive brain stimulation, such as TMS. This work has also involved collaborations across campus and with colleagues at other institutions, such as the National Network of Depression Centers, where he co-directed a multi-site TMS trial. He also started and directs the TMS program in the Department of Psychiatry, providing treatment for patients with refractory depression. His other area of clinical expertise is in the treatment of schizophrenia and related psychotic disorders. He founded and directs the Program for Risk Evaluation and Prevention (PREP) early psychosis clinic to provide state-of-the art, multi-specialty evaluation and treatment for early psychosis, as well as conducting research in this population. This work in psychosis has also included national collaborations through the NIMH-funded Early Psychosis Intervention Network, which has laid the foundations for a learning health system.
Dr. Taylor is a past present of the Psychiatric Research Society, a fellow of the American Association for the Advancement of Science and the American College of Neuropsychopharmacology. His research has been funded by the National Institute of Mental Health, Brain and Behavior Research Foundation, National Alliance for the Mentally Ill, and more. He has published over 190 peer-reviewed articles and serves on numerous editorial boards, grant review committees and national advisory boards.
Recent Publications
-
Bornheimer LA, DeVylder J, Smith MJ, Brdar NM, Campbell M, Kelter AN, Anderson E, Xu S, Honer K, Florence T, McKay MM, Dixon L, Tarrier N, King CA, Taylor SF, Himle JA. Schizophrenia Research, 2026 Nov 1; 297: 140 - 148.Journal ArticleCognitive-behavioral suicide prevention for psychosis in community mental health: A pilot randomized clinical trial
DOI:10.1016/j.schres.2026.08.001 PMID: 42570386 -
Moe AM, Blain SD, Kalathil A, Angstadt M, Peltier S, Diwadkar V, Taylor SF, Tso IF. Biological Psychiatry Cognitive Neuroscience and Neuroimaging, 2026 Oct 1; 11 (10): 1238 - 1249.Journal ArticleCerebellum-Cerebrum Dynamics During Gaze Processing in Schizophrenia: Evidence for Social-Cognitive Modulation and Associations With Social Functioning Across Independent Samples
DOI:10.1016/j.bpsc.2026.05.008 PMID: 42203032 -
Lasagna CA, Kraft J, Nunez MD, Suzuki T, Grove T, Taylor SF, Tso IF, Pleskac TJ. 2026 Sep 29; PsyArXiv,PreprintSelf-Referential Social Processing in Schizophrenia and Bipolar Disorder: Advancing Theoretical Precision and Clinical Insights with Model-Based Neuroscience
DOI:10.31234/osf.io/ucbhr_v1 -
Suzuki T, Menkes MW, Walton M, McInnis MG, Kang J, Niendam TA, Tso IF, Taylor SF. 2026 Sep 23; PsyArXiv,PreprintCognitive Control Neural Correlates of Negative Affective in Psychosis Spectrum Disorders: A Laboratory and Ecological Momentary Assessment Study
DOI:10.31234/osf.io/f7yzs_v1 -
Tayfur SN, Vohs JL, Chaudhry S, Song Z, Li F, Breitborde NJK, Cahill J, Heckers S, Satchivi A, Silverstein S, Taylor SF, Tso IF, Weiss A, Breier A, Srihari VH. Psychiatr Serv, 2026 Aug 27; appips20260106Journal ArticleDischarge From Coordinated Specialty Care: Timing, Reasons, and Predictors in a National Early Psychosis Network.
DOI:10.1176/appi.ps.20260106 PMID: PMC13654296 -
Kraft JD, Locarno L, Suzuki T, Riddle J, Chang SE, McInnis MG, Fröhlich F, Taylor SF, Tso IF. Bipolar Disorders, 2026 Aug 1; 28 (5):Journal ArticleEnhancing Affective Cognitive Control in Bipolar Disorder Using Transcranial Alternating Current Stimulation: A Double-Blind, Randomized, Sham-Controlled Clinical Trial and Proof of Concept Study
DOI:10.1111/bdi.70142 PMID: 42381254 -
Miller CR, Taylor SF, Breier A, Vohs JL, Burton CZ. Schizophrenia Research, 2026 Aug 1; 294: 1 - 6.Journal ArticleFactor analysis of two COMPASS psychopathology symptom scales for first-episode psychosis
DOI:10.1016/j.schres.2026.04.008 PMID: 41996961 -
Taylor SF. Neuropsychopharmacology, 2026 Jul 7;Journal ArticleIn memoriam: Jon Kar Zubieta, M.D., Ph.D.
DOI:10.1038/s41386-026-02493-0 PMID: 42414565
Featured News & Stories
Stephan Taylor, M.D., quoted in Ars Technica story, "Man told ChatGPT he was feeling delusional. ChatGPT insisted he was Jesus"
Check out The Pulse, Psychiatry's e-newsletter, with news, events, and more for this fall
Dr. Steve Taylor penned the op-ed for the U-M VP of Research's Michigan Research newsletter's May edition
AI chatbots spark mental health concerns, including psychosis risk
Check out The Pulse, Psychiatry's e-newsletter, with news, events, and more for May - Mental Health Month